{"id":154742,"date":"2026-06-15T06:54:13","date_gmt":"2026-06-15T14:54:13","guid":{"rendered":"https:\/\/xira.com\/p\/2026\/06\/15\/amgen-turns-to-an-independent-review-to-defend-rare-disease-drug-in-fda-crosshairs\/"},"modified":"2026-06-15T06:54:13","modified_gmt":"2026-06-15T14:54:13","slug":"amgen-turns-to-an-independent-review-to-defend-rare-disease-drug-in-fda-crosshairs","status":"publish","type":"post","link":"https:\/\/xira.com\/p\/2026\/06\/15\/amgen-turns-to-an-independent-review-to-defend-rare-disease-drug-in-fda-crosshairs\/","title":{"rendered":"Amgen Turns To An Independent Review To Defend Rare Disease Drug In FDA Crosshairs"},"content":{"rendered":"<p>The post <a href=\"https:\/\/medcitynews.com\/2026\/06\/amgen-tavneos-anca-associated-vasculitis-inflammation-fda-dcri-amgn\/\" rel=\"nofollow noopener\" target=\"_blank\">Amgen Turns To An Independent Review To Defend Rare Disease Drug In FDA Crosshairs<\/a> appeared first on <a href=\"https:\/\/abovethelaw.com\/\" rel=\"nofollow noopener\" target=\"_blank\">Above the Law<\/a>.<\/p>\n<p>The post <a href=\"https:\/\/medcitynews.com\/2026\/06\/amgen-tavneos-anca-associated-vasculitis-inflammation-fda-dcri-amgn\/\" rel=\"nofollow noopener\" target=\"_blank\">Amgen Turns To An Independent Review To Defend Rare Disease Drug In FDA Crosshairs<\/a> appeared first on <a href=\"https:\/\/abovethelaw.com\/\" rel=\"nofollow noopener\" target=\"_blank\">Above the Law<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The post Amgen Turns To An Independent Review To Defend Rare Disease Drug In FDA Crosshairs appeared first on Above the Law. The post Amgen Turns To An Independent Review To Defend Rare Disease Drug In FDA Crosshairs appeared first on Above the Law.<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[16],"tags":[],"class_list":["post-154742","post","type-post","status-publish","format-standard","hentry","category-above_the_law"],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/posts\/154742","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/comments?post=154742"}],"version-history":[{"count":0,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/posts\/154742\/revisions"}],"wp:attachment":[{"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/media?parent=154742"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/categories?post=154742"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/tags?post=154742"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}